Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kosuda, S.
Right arrow Articles by Kusano, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kosuda, S.
Right arrow Articles by Kusano, S.
(Chest. 2000;117:346-353.)
© 2000 American College of Chest Physicians

Decision-Tree Sensitivity Analysis for Cost-Effectiveness of Chest 2-Fluoro-2-D-[18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Pulmonary Nodules (Non-small Cell Lung Carcinoma) in Japan*

Shigeru Kosuda, MD; Kiyoshi Ichihara, MD, PhD; Masumi Watanabe, MD; Hideo Kobayashi, MD, FCCP and Shoichi Kusano, MD

* From the Department of Radiology (Dr. Kosuda), Department of Surgery (Dr. Watanabe), and Department of Internal Medicine (Dr. Kobayashi), National Defense Medical College, Tokorozawa, Japan; and the Department of Diagnosis (Dr. Ichihara), Kawasaki Medical College, Kurashiki, Japan. Partially supported by funding from the Working Group Project of the Japanese Society of Nuclear Medicine.

Correspondence to: Shigeru Kosuda, MD, Department of Radiology, National Defense Medical College, 3–2 Namiki Tokorozawa 359-8513, Japan; e-mail: nucleark{at}infokanto.ne.jp

Context: Recent studies have demonstrated the potential cost-effectiveness of using 2-fluoro-2-D-[18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in the management of non-small cell lung carcinoma (NSCLC), but because of differences in health-care systems, those findings may not hold true in a Japanese hospital.

Objective: To assess the cost-effectiveness of the chest CT plus chest FDG-PET strategy in Japan.

Design: Decision-tree sensitivity analysis based on the two competing strategies of chest CT–alone vs chest CT plus chest FDG-PET.

Study selection: A simulation of 1,000 patients in whom NSCLC, stage IIIB or less, was suspected was created using baselines of other relevant variables in regard to sensitivity, specificity, mortality, life expectancy, and cost from published data.

Methods: We surveyed the relevant literature for the choice of variables.

Main outcome measures: Expected marginal cost and expected life expectancy gain for NSCLC patients.

Results: The chest CT plus chest FDG-PET strategy yielded an expected life expectancy gain of 0.607 years (7.3 months) per patient, compared with the alternative strategy of chest CT–alone. Using an FDG-PET examination cost of 1.0 x 105 yen (around $700 US) per study, the cost increment was 2.18 x 105 yen/yr/patient.

Conclusions: The chest CT plus chest FDG-PET strategy in patients with NSCLC is unlikely to be cost-effective in Japan. However, patient life expectancy gain would increase as a result of improved staging of NSCLC. These preliminary results should be confirmed by further studies for specific environments.

Key Words: cost-effectiveness • 2-fluoro-2-D-[18F]fluorodeoxyglucose positron emission tomography • life expectancy • non-small cell lung carcinoma




This article has been cited by other articles:


Home page
J Natl Cancer Inst MonogrHome page
C. C. Earle
Outcomes Research in Lung Cancer
J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 56 - 77.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. Berger, M. K. Gould, and P. G. Barnett
The Cost of Positron Emission Tomography in Six United States Veterans Affairs Hospitals and Two Academic Medical Centers
Am. J. Roentgenol., August 1, 2003; 181(2): 359 - 365.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.